全文获取类型
收费全文 | 18350篇 |
免费 | 1137篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 149篇 |
儿科学 | 481篇 |
妇产科学 | 375篇 |
基础医学 | 2480篇 |
口腔科学 | 633篇 |
临床医学 | 1291篇 |
内科学 | 4755篇 |
皮肤病学 | 459篇 |
神经病学 | 1585篇 |
特种医学 | 417篇 |
外科学 | 2546篇 |
综合类 | 118篇 |
一般理论 | 8篇 |
预防医学 | 1263篇 |
眼科学 | 642篇 |
药学 | 911篇 |
中国医学 | 66篇 |
肿瘤学 | 1354篇 |
出版年
2023年 | 137篇 |
2022年 | 89篇 |
2021年 | 523篇 |
2020年 | 360篇 |
2019年 | 511篇 |
2018年 | 627篇 |
2017年 | 398篇 |
2016年 | 408篇 |
2015年 | 552篇 |
2014年 | 666篇 |
2013年 | 893篇 |
2012年 | 1440篇 |
2011年 | 1541篇 |
2010年 | 828篇 |
2009年 | 785篇 |
2008年 | 1345篇 |
2007年 | 1373篇 |
2006年 | 1323篇 |
2005年 | 1173篇 |
2004年 | 1000篇 |
2003年 | 977篇 |
2002年 | 900篇 |
2001年 | 133篇 |
2000年 | 99篇 |
1999年 | 128篇 |
1998年 | 117篇 |
1997年 | 94篇 |
1996年 | 88篇 |
1995年 | 100篇 |
1994年 | 100篇 |
1993年 | 80篇 |
1992年 | 47篇 |
1991年 | 52篇 |
1990年 | 39篇 |
1989年 | 37篇 |
1988年 | 33篇 |
1987年 | 37篇 |
1986年 | 29篇 |
1985年 | 31篇 |
1984年 | 43篇 |
1983年 | 34篇 |
1982年 | 36篇 |
1981年 | 50篇 |
1980年 | 22篇 |
1979年 | 23篇 |
1978年 | 32篇 |
1977年 | 26篇 |
1976年 | 28篇 |
1973年 | 20篇 |
1969年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 16 毫秒
1.
2.
Prajwal C. Boddu MD Tapan M. Kadia MD Guillermo Garcia-Manero MD Jorge Cortes MD Mansour Alfayez MD Gautam Borthakur MD Marina Konopleva MD PhD Elias J. Jabbour MD Naval G. Daver MD Courtney D. DiNardo MD Kiran Naqvi MD Musa Yilmaz MD Nicholas J. Short MD Sherry Pierce MD Hagop M. Kantarjian MD Farhad Ravandi MD 《Cancer》2019,125(7):1091-1100
3.
4.
Patrick Williams MD PhD Sreyashi Basu PhD Guillermo Garcia-Manero MD Christopher S. Hourigan MD PhD Karolyn A. Oetjen MD PhD Jorge E. Cortes MD Farhad Ravandi MD Elias J. Jabbour MD Zainab Al-Hamal MD Marina Konopleva MD PhD Jing Ning PhD Lianchun Xiao PhD Juliana Hidalgo Lopez MD Steve M. Kornblau MD Michael Andreeff MD PhD Wilmer Flores BSc Carlos Bueso-Ramos MD PhD Jorge Blando DVM Pallavi Galera MD Katherine R. Calvo MD PhD Gheath Al-Atrash DO PhD James P. Allison PhD Hagop M. Kantarjian MD Padmanee Sharma MD PhD Naval G. Daver MD 《Cancer》2019,125(9):1470-1481
5.
Kamal Chamoun MD Hagop M. Kantarjian MD Xuemei Wang MS Kiran Naqvi MD Fleur Aung MD Guillermo Garcia-Manero MD Gautam Borthakur MD Elias Jabbour MD Tapan Kadia MD Naval Daver MD Courtney D. DiNardo MD Nitin Jain MD Marina Konopleva MD Jorge Cortes MD Farhad Ravandi MD Musa Yilmaz MD 《Cancer》2019,125(18):3219-3224
6.
Sandra Esperanza Díaz-Casas Jorge Alberto Castilla-Tarra Esperanza Pena-Torres Martha Orozco-Ospino Sara Mendoza-Diaz Marcela Nuñez-Lemus Oscar Garcia-Angulo Mauricio Garcia-Mora Luis Guzman-AbiSaab Carlos Lehmann-Mosquera Javier Angel-Aristizabal Carlos Duarte-Torres Juan Carlos Vergel-Martinez 《The oncologist》2019,24(12):e1360-e1370
7.
Kiran Naqvi MD Elias Jabbour MD Jeffrey Skinner BS MHA Kristin Anderson BS Sara Dellasala BS Musa Yilmaz MD Alessandra Ferrajoli MD Prithviraj Bose MD Philip Thompson MBBS Yesid Alvarado MD Nitin Jain MBBS Koichi Takahashi MD Jan Burger MD Zeev Estrov MD Gautam Borthakur MBBS Naveen Pemmaraju MD Shilpa Paul Pharm D Jorge Cortes MD Hagop M. Kantarjian MD 《Cancer》2020,126(1):67-75
8.
Deepti Bettampadi Luisa L. Villa Eduardo L. Ponce Jorge Salmeron Bradley A. Sirak Martha Abrahamsen Julie A. Rathwell Richard R. Reich Anna R. Giuliano 《International journal of cancer. Journal international du cancer》2020,146(11):3026-3033
Incidence of human papillomavirus (HPV) attributable oropharyngeal cancers (OPCs) has been increasing globally, especially among men in high-income countries. There is a lack of studies comparing oral HPV prevalence by age and country among healthy men. The purpose of our study was to assess oral HPV prevalence by country and age. Participants of the HPV Infection in Men Study (HIM), a cohort of 3,098 healthy men from São Paulo, Brazil, Cuernavaca, Mexico and Tampa, USA, were studied. Oral HPV prevalence and type distribution were assessed using the SPF10 PCR-DEIA-LiPA25 system. The prevalence of any HPV in Brazil, Mexico and the US was 8.7% (95% CI: 7.1%, 10.4%), 10.0% (95% CI: 8.3%, 12.1%) and 7.6% (95% CI: 5.9%, 9.5%), respectively, while the prevalence of high-risk HPV was 5.3% (95% CI: 4.1%, 6.7%), 7.3% (95% CI: 5.7%, 9.0%) and 5.4% (95% CI: 4.0%, 7.0%), respectively. No significant differences in prevalence of grouped HPV types were observed by country despite significant differences in sexual behaviors. However, the age-specific prevalence of oral HPV differed by country. Brazilian (6.0% [95% CI: 3.4%, 9.7%]) and Mexican (9.2% [95% CI: 5.6%, 14.0%]) participants had peak high-risk HPV prevalence among men aged 41–50 years whereas the US participants had peak prevalence at ages 31–40 years (11.0% [95% CI: 6.4%, 17.3%]). In conclusion, oral HPV prevalence was low with no difference in overall prevalence observed by country. Factors associated with the differences in oral HPV age-patterning by country and sexual orientation require further study. 相似文献
9.
Gregory M. Videtic Rebecca Paulus Anurag K. Singh Joe Y. Chang William Parker Kenneth R. Olivier Robert D. Timmerman Ritsuko R. Komaki James J. Urbanic Kevin L. Stephans Sue S. Yom Clifford G. Robinson Chandra P. Belani Puneeth Iyengar Munther I. Ajlouni Darindra D. Gopaul Jorge B. Gomez Suescun Ronald C. McGarry Jeffrey D. Bradley 《International journal of radiation oncology, biology, physics》2019,103(5):1077-1084